Loss of vascular CD34 results in increased sensitivity to lung injury

Bernard C. Lo, Matthew J. Gold, Sebastian Scheer, Michael R. Hughes, Jessica Cait, Erin Debruin, Fanny S.F. Chu, David C. Walker, Hesham Soliman, Fabio M. Rossi, Marie Renee Blanchet, Georgia Perona-Wright, Colby Zaph, Kelly M. McNagny

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)

Abstract

Survival during lung injury requires a coordinated program of damage limitation and rapid repair. CD34 is a cell surface sialomucin expressed by epithelial, vascular, and stromal cells that promotes cell adhesion, coordinates inflammatory cell recruitment, and drives angiogenesis. To test whether CD34 also orchestrates pulmonary damage and repair, we induced acute lung injury in wild-type (WT) and Cd342/2 mice by bleomycin administration. We found that Cd342/2 mice displayed severe weight loss and early mortality compared with WT controls. Despite equivalent early airway inflammation to WT mice, CD34-deficient animals developed interstitial edema and endothelial delamination, suggesting impaired endothelial function. Chimeric Cd342/2mice reconstituted withWT hematopoietic cells exhibited early mortality compared with WT mice reconstituted with Cd342/2 cells, supporting an endothelial defect. CD34-deficient mice were also more sensitive to lung damage caused by influenza infection, showing greater weight loss and more extensive pulmonary remodeling. Together, our data suggest that CD34 plays an essential role in maintaining vascular integrity in the lung in response to chemical- and infection-induced tissue damage.

Original languageEnglish
Pages (from-to)651-661
Number of pages11
JournalAmerican Journal of Respiratory Cell and Molecular Biology
Volume57
Issue number6
DOIs
Publication statusPublished - 1 Dec 2017

Keywords

  • Bleomycin
  • CD34
  • Influenza
  • Lung injury
  • Vascular endothelia

Cite this